Recall StatusTerminated
Date Initiated2009-03-23
Date Terminated2012-07-10
Product Quantity8499 US
Reason for Recall
Routine monitoring of Medtronic's vigilance program identified user related programming errors. Medtronic has received reports of both overdose and underdose that were the result of programming use of SynchroMed implantable infusion pumps. These errors were most commonly associated with: --Priming Bolus Programming; and --Bridge Bolus Programming. Pump programming errors that result in overdos
Firm Action
Medtronic is exchanging 8870 versions AAG, AAJ and BBG and replacing it with the updated versions AAH01 and BBH01. The updated versions contain user interface improvements to reduce the chance of user related programming errors when programming SynchroMed II and SynchroMed EL Infusion Pump system.
A Medtronic "Medical Device Correction" letter was left behind for consignees. The letter was addressed to "Healthcare Provider" and was dated February 2009. The letter provided information regarding changes to the programming software used in SynchorMed Infusion System.
For additional information, please contact your Medtronic Representative or Medtronic Neuromodulation Technical Services at 1-800-707-0933.
Distribution Pattern
All States in the US including DC.
OUS: Austria
Belgium
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Faroe Islands
Finland
France
French Polynesia
Germany
Greece
Hungary
India
Ireland
Israel
Italy
Kuwait
Lebanon
Malta
Martinique
Netherlands
New Caledonia
Norway
Poland
Portugal
Reunion
Russian Federation
San Marino
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Kingdom
Vatican City State
Canada
Mexico
Brasil
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.